These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22590529)

  • 1. High interstitial fluid pressure is associated with low tumour penetration of diagnostic monoclonal antibodies applied for molecular imaging purposes.
    Heine M; Freund B; Nielsen P; Jung C; Reimer R; Hohenberg H; Zangemeister-Wittke U; Wester HJ; Lüers GH; Schumacher U
    PLoS One; 2012; 7(5):e36258. PubMed ID: 22590529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations on the usefulness of CEACAMs as potential imaging targets for molecular imaging purposes.
    Heine M; Nollau P; Masslo C; Nielsen P; Freund B; Bruns OT; Reimer R; Hohenberg H; Peldschus K; Ittrich H; Schumacher U
    PLoS One; 2011; 6(12):e28030. PubMed ID: 22162753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic potential of amanitin-conjugated anti-epithelial cell adhesion molecule monoclonal antibody against pancreatic carcinoma.
    Moldenhauer G; Salnikov AV; Lüttgau S; Herr I; Anderl J; Faulstich H
    J Natl Cancer Inst; 2012 Apr; 104(8):622-34. PubMed ID: 22457476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary cervical carcinoma cell lines overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody.
    Richter CE; Cocco E; Bellone S; Bellone M; Casagrande F; Todeschini P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Int J Gynecol Cancer; 2010 Dec; 20(9):1440-7. PubMed ID: 21370592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An anti-EpCAM antibody EpAb2-6 for the treatment of colon cancer.
    Liao MY; Lai JK; Kuo MY; Lu RM; Lin CW; Cheng PC; Liang KH; Wu HC
    Oncotarget; 2015 Sep; 6(28):24947-68. PubMed ID: 26317650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the specificity and selectivity of anti-EpCAM antibodies in breast cancer cell lines.
    Sterzynska K; Kempisty B; Zawierucha P; Zabel M
    Folia Histochem Cytobiol; 2012; 50(4):534-41. PubMed ID: 23264216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution and radioimmunotherapy of SCCHN in xenotransplantated SCID mice with a 131I-labelled anti-EpCAM monoclonal antibody.
    Andratschke M; Gildehaus FJ; Johannson V; Schmitt B; Mack B; Reisbach G; Lang S; Lindhofer H; Zeidler R; Wollenberg B; Luebbers CW
    Anticancer Res; 2007; 27(1A):431-6. PubMed ID: 17352264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of EpCAM in uterine serous papillary carcinoma: implications for EpCAM-specific immunotherapy with human monoclonal antibody adecatumumab (MT201).
    El-Sahwi K; Bellone S; Cocco E; Casagrande F; Bellone M; Abu-Khalaf M; Buza N; Tavassoli FA; Hui P; Rüttinger D; Silasi DA; Azodi M; Schwartz PE; Rutherford TJ; Pecorelli S; Santin AD
    Mol Cancer Ther; 2010 Jan; 9(1):57-66. PubMed ID: 20053761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodistribution studies of epithelial cell adhesion molecule (EpCAM)-directed monoclonal antibodies in the EpCAM-transgenic mouse tumor model.
    Kosterink JG; McLaughlin PM; Lub-de Hooge MN; Hendrikse HH; van Zanten J; van Garderen E; Harmsen MC; de Leij LF
    J Immunol; 2007 Jul; 179(2):1362-8. PubMed ID: 17617629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor antigen EpCAM: tetraspanins and the tight junction protein claudin-7, new partners, new functions.
    Le Naour F; Zoller M
    Front Biosci; 2008 May; 13():5847-65. PubMed ID: 18508627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between ganglioside expression and anti-cancer effects of the monoclonal antibody against epithelial cell adhesion molecule in colon cancer.
    Kwak DH; Ryu JS; Kim CH; Ko K; Ma JY; Hwang KA; Choo YK
    Exp Mol Med; 2011 Dec; 43(12):693-701. PubMed ID: 22033101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial glycoprotein-2 expression is subject to regulatory processes in epithelial-mesenchymal transitions during metastases: an investigation of human cancers transplanted into severe combined immunodeficient mice.
    Jojović M; Adam E; Zangemeister-Wittke U; Schumacher U
    Histochem J; 1998 Oct; 30(10):723-9. PubMed ID: 9873999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.
    Spizzo G; Fong D; Wurm M; Ensinger C; Obrist P; Hofer C; Mazzoleni G; Gastl G; Went P
    J Clin Pathol; 2011 May; 64(5):415-20. PubMed ID: 21415054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial cell adhesion molecule expression (CD326) in cancer: a short review.
    Patriarca C; Macchi RM; Marschner AK; Mellstedt H
    Cancer Treat Rev; 2012 Feb; 38(1):68-75. PubMed ID: 21576002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genome-wide expression analysis identifies a network of EpCAM-induced cell cycle regulators.
    Maaser K; Borlak J
    Br J Cancer; 2008 Nov; 99(10):1635-43. PubMed ID: 19002182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EpCAM: A new therapeutic target for an old cancer antigen.
    Armstrong A; Eck SL
    Cancer Biol Ther; 2003; 2(4):320-6. PubMed ID: 14508099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EpCAM, a new marker for cancer stem cells in hepatocellular carcinoma.
    Terris B; Cavard C; Perret C
    J Hepatol; 2010 Feb; 52(2):280-1. PubMed ID: 20006402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of sensitive chemical antibodies for diagnosis: detection of low levels of EpCAM in breast cancer.
    Shigdar S; Qian C; Lv L; Pu C; Li Y; Li L; Marappan M; Lin J; Wang L; Duan W
    PLoS One; 2013; 8(2):e57613. PubMed ID: 23460885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3.
    Amann M; Brischwein K; Lutterbuese P; Parr L; Petersen L; Lorenczewski G; Krinner E; Bruckmeier S; Lippold S; Kischel R; Lutterbuese R; Kufer P; Baeuerle PA; Schlereth B
    Cancer Res; 2008 Jan; 68(1):143-51. PubMed ID: 18172306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE), is highly active against primary uterine serous papillary carcinoma cell lines in vitro.
    Bellone S; Black J; English DP; Schwab CL; Lopez S; Cocco E; Bonazzoli E; Predolini F; Ferrari F; Ratner E; Silasi DA; Azodi M; Schwartz PE; Santin AD
    Am J Obstet Gynecol; 2016 Jan; 214(1):99.e1-8. PubMed ID: 26272866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.